Federal law requires a health warning on every tobacco product sold in the United States, and the exact language, size, and placement of those tobacco warning labels depend on whether the product is a cigarette, smokeless tobacco, an e-cigarette, or a cigar. The Family Smoking Prevention and Tobacco Control Act of 2009 gave the Food and Drug Administration authority over tobacco labeling, and a 2016 “deeming rule” pulled e-cigarettes, cigars, pipe tobacco, hookah tobacco, and dissolvable products under the same umbrella.1Food and Drug Administration. FDA’s Deeming Regulations for E-Cigarettes, Cigars, and All Other Tobacco Products What follows is what the label has to say, how it has to look, and what happens when it doesn’t.
What the Label Must Say
The required text turns on product category. Cigarettes, smokeless tobacco, and deemed products each carry a distinct set of warnings.
Cigarettes
The Federal Cigarette Labeling and Advertising Act, as amended by the Tobacco Control Act, identifies 11 required health warnings for cigarette packages and advertisements. They cover head and neck cancer, fatal lung disease in nonsmokers, type 2 diabetes, limb amputation from reduced blood flow, cataracts, bladder cancer, erectile dysfunction, COPD, heart disease and strokes, and harm to fetal growth during pregnancy.2U.S. Food and Drug Administration. Cigarette Labeling and Health Warning Requirements Each begins with “WARNING” in capital letters.
These 11 warnings are not currently on packs. Federal courts have blocked them, and the older four-rotation Surgeon General warnings that have appeared on cigarette packs for decades remain the operative requirement. The litigation is covered further below.
Smokeless Tobacco
Smokeless tobacco packages must display one of four rotating warnings under the Comprehensive Smokeless Tobacco Health Education Act:
- “WARNING: This product can cause mouth cancer.”
- “WARNING: This product can cause gum disease and tooth loss.”
- “WARNING: This product is not a safe alternative to cigarettes.”
- “WARNING: Smokeless tobacco is addictive.”
A manufacturer cannot sell, distribute, or import smokeless tobacco in the United States unless the package carries one of those four statements.3Office of the Law Revision Counsel. 15 U.S.C. 4402 – Smokeless Tobacco Warning
E-Cigarettes, Cigars, and Other Deemed Products
Products brought under FDA jurisdiction by the 2016 deeming rule carry a nicotine warning: “WARNING: This product contains nicotine. Nicotine is an addictive chemical.” If a tobacco-derived product genuinely contains no nicotine and the manufacturer has data to certify that, the statement is replaced with: “This product is made from tobacco.”4eCFR. 21 CFR 1143.3 – Required Warning Statement
Cigars sold individually without packaging shift the labeling burden to the retailer, who is supposed to display all six cigar warnings on a sign at the point of sale. A 2020 federal court order vacated the cigar health warning requirements, so compliance with those specific provisions is currently voluntary.5U.S. Food and Drug Administration. Retailers: Chart of Required Warning Statements on Tobacco Product Packaging and Advertising
Size, Placement, and Design Rules
On a cigarette package, the warning has to cover at least the top 50 percent of the front and rear panels. On a carton, it takes at least the left 50 percent of the front and rear panels. Text is printed in 17-point type, unless that would fill more than 70 percent of the warning area, in which case a smaller size is allowed as long as text still occupies at least 60 percent of the space.6Office of the Law Revision Counsel. 15 U.S.C. 1333 – Labeling All text appears in black on white or white on black, contrasting with the rest of the packaging.
In print and poster advertisements, the warning takes at least 20 percent of the total ad area and sits in a conspicuous spot at the top. Font size scales with the ad: a full-page broadsheet newspaper ad requires 45-point type, and a 20-by-2-column ad requires 15-point type. The same black-on-white or white-on-black color rule applies.
Warnings have to be permanent. They can’t be obscured by cellophane wrapping, overlapping graphics, or brand imagery, and they must remain clearly visible through any clear outer wrapping.
Where Graphic Warnings Stand Now
In March 2020, the FDA finalized a rule requiring photorealistic color images alongside each of the 11 textual warnings on cigarette packages and advertisements.2U.S. Food and Drug Administration. Cigarette Labeling and Health Warning Requirements The combined text-and-image warnings would cover the top 50 percent of the front and rear panels. Images were matched to specific health consequences: a tracheostomy for head and neck cancer, damaged lungs for COPD, a foot amputation for reduced blood flow, and similar depictions for each warning.
Manufacturers would have rotated the warnings in roughly equal numbers across each brand every 12 months and distributed them evenly across geographic markets, with quarterly rotation in advertisements. Each rotation plan required FDA approval before implementation.7eCFR. 21 CFR Part 1141 – Required Warnings for Cigarette Packages and Advertisements
None of it is in effect. In January 2025, the U.S. District Court for the Eastern District of Texas preliminarily enjoined the FDA from enforcing the rule. On August 29, 2025, the U.S. District Court for the Southern District of Georgia vacated the rule entirely in Philip Morris USA Inc. v. FDA. The FDA has appealed, but as of early 2026, no graphic health warnings are required on cigarette packaging or advertisements, and the older four Surgeon General warnings still control.
Why States Can’t Add Their Own Warnings
A state or city cannot layer additional label requirements on top of the federal ones. The Federal Cigarette Labeling and Advertising Act bars any state from imposing smoking-and-health requirements on cigarette advertising or promotion beyond federal law, so long as the manufacturer’s packaging complies.8Office of the Law Revision Counsel. 15 U.S.C. 1334 – Preemption The Tobacco Control Act goes further: under 21 U.S.C. ยง 387p, no state or local government can establish tobacco labeling, misbranding, adulteration, manufacturing, or premarket review requirements that differ from or add to the federal standard.9Office of the Law Revision Counsel. 21 U.S.C. 387p – Preservation of State and Local Authority
States keep authority over minimum purchase age enforcement, sales restrictions, advertising promotion, and fire safety standards. The health warning on the package itself is strictly federal.
Penalties for Missing or Non-Compliant Warnings
A tobacco product without the required warning is “misbranded” under federal law, and shipping a misbranded product into interstate commerce is a prohibited act.10Office of the Law Revision Counsel. 21 U.S. Code 331 – Prohibited Acts Enforcement escalates from a letter to fines to seizure.
Warning Letters
The first step is usually a warning letter identifying the labeling deficiency and demanding corrective action. Companies generally have 15 working days to respond with a fix. Warning letters are public records.
Civil Money Penalties for Manufacturers
If the violation isn’t corrected, the FDA can pursue civil money penalties. For standard violations under the Federal Food, Drug, and Cosmetic Act, the base statutory cap is $15,000 per violation and $1,000,000 for all violations in a single enforcement proceeding. Intentional violations of certain provisions, including manufacturing standards and premarket review, jump to $250,000 per violation, doubling every 30 days a violation continues after written notice, up to $10,000,000 in a single proceeding.11Office of the Law Revision Counsel. 21 U.S.C. 333 – Penalties Amounts are adjusted annually for inflation. As of 2026, the inflation-adjusted cap on a single standard violation is $21,903.12Food and Drug Administration. Advisory and Enforcement Actions Against Industry for Selling Tobacco Products to Underage Purchasers
Retailer Penalties
Retailers face a separate graduated schedule. A first violation draws a warning letter with no fine. A second violation within 12 months triggers a $365 penalty. By the sixth violation within 48 months, the fine reaches $14,602. A retailer with five or more violations within 36 months risks a no-tobacco-sale order, which prohibits sale of all regulated tobacco products at that location for a set period. The FDA sets the duration based on the severity of the violations, the retailer’s compliance history, and the retailer’s ability to continue operating.12Food and Drug Administration. Advisory and Enforcement Actions Against Industry for Selling Tobacco Products to Underage Purchasers
Product Seizure and Detention
The FDA can seize misbranded tobacco products through a federal court proceeding. Any adulterated or misbranded product found in interstate commerce can be seized by court order and either destroyed or sold under court supervision, with proceeds going to the U.S. Treasury. Short of a full seizure, an inspector who encounters misbranded product during a facility or vehicle inspection can issue an administrative detention order, holding the product in place for up to 20 days, extendable to 30 days if the agency needs more time to initiate formal proceedings.13Office of the Law Revision Counsel. 21 U.S.C. 334 – Seizure
The tools are calibrated to scale. A small retailer selling a few mislabeled products can expect a warning letter and a modest fine. A manufacturer shipping misbranded product across the country faces penalties in the millions and the prospect of having inventory pulled before it reaches shelves.